Advertisement
UK markets closed

  • NIKKEI 225

    38,835.10
    +599.03 (+1.57%)
     

  • HANG SENG

    18,479.37
    -98.93 (-0.53%)
     

  • CRUDE OIL

    78.54
    +0.06 (+0.08%)
     

  • GOLD FUTURES

    2,323.40
    -7.80 (-0.33%)
     

  • DOW

    38,873.38
    +21.11 (+0.05%)
     

  • Bitcoin GBP

    50,539.41
    +91.86 (+0.18%)
     

  • CMC Crypto 200

    1,307.87
    -57.25 (-4.19%)
     

  • NASDAQ Composite

    16,334.85
    -14.39 (-0.09%)
     

  • UK FTSE All Share

    4,522.99
    +53.90 (+1.21%)
     
Money:

The retirement income gap no-one is talking about

People are living longer than ever before and this can impact how you plan for retirement

Nasdaq Scheduled Resumption in Moleculin Biotech, Inc.

GlobeNewswire

NEW YORK, May 27, 2020 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (NDAQ) announced that trading in Moleculin Biotech, Inc. (MBRX) is scheduled to resume on Thursday, May 28, 2020, at 7:00 a.m. Eastern Time. Trading in the company’s stock was halted on May 4, 2020 at 9:25:06 Eastern Time.

For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotesSM on the Nasdaq® Web site.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com.

NDAQO

Nasdaq Media Contact:
Bianca Fata
Bianca.Fata@nasdaq.com